These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
481 related articles for article (PubMed ID: 24418410)
21. Prevention of common neurodegenerative disorders in the elderly. Fratiglioni L; Qiu C Exp Gerontol; 2009; 44(1-2):46-50. PubMed ID: 18620039 [TBL] [Abstract][Full Text] [Related]
22. Prevention of Alzheimer's disease: a global challenge for next generation neuroscientists. Rodríguez-Gómez O; Palacio-Lacambra ME; Palasí A; Ruiz-Laza A; Boada-Rovira M J Alzheimers Dis; 2014; 42 Suppl 4():S515-23. PubMed ID: 25351111 [TBL] [Abstract][Full Text] [Related]
23. Lifestyle interventions to prevent cognitive impairment, dementia and Alzheimer disease. Kivipelto M; Mangialasche F; Ngandu T Nat Rev Neurol; 2018 Nov; 14(11):653-666. PubMed ID: 30291317 [TBL] [Abstract][Full Text] [Related]
24. [Physical activity and prevention of Alzheimer's dementia: current evidence and feasibility of an interventional trial]. Weih M; Abu-Omar K; Esselmann H; Gelbrich G; Lewczuk P; Rütten A; Wiltfang J; Kornhuber J Fortschr Neurol Psychiatr; 2009 Mar; 77(3):146-51. PubMed ID: 19283649 [TBL] [Abstract][Full Text] [Related]
25. A 12-week multidomain intervention versus active control to reduce risk of Alzheimer's disease: study protocol for a randomized controlled trial. Anstey KJ; Bahar-Fuchs A; Herath P; Rebok GW; Cherbuin N Trials; 2013 Feb; 14():60. PubMed ID: 23442574 [TBL] [Abstract][Full Text] [Related]
26. Preventive benefits of natural nutrition and lifestyle counseling against Alzheimer's disease onset. Polidori MC J Alzheimers Dis; 2014; 42 Suppl 4():S475-82. PubMed ID: 25238764 [TBL] [Abstract][Full Text] [Related]
27. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action. Brinton RD Ann N Y Acad Sci; 2005 Jun; 1052():57-74. PubMed ID: 16024751 [TBL] [Abstract][Full Text] [Related]
28. Preventing Alzheimer's disease by targeting vascular risk factors: hope and gap. Qiu C J Alzheimers Dis; 2012; 32(3):721-31. PubMed ID: 22842870 [TBL] [Abstract][Full Text] [Related]
29. The vascular hypothesis of Alzheimer's disease: bench to bedside and beyond. de la Torre JC Neurodegener Dis; 2010; 7(1-3):116-21. PubMed ID: 20173340 [TBL] [Abstract][Full Text] [Related]
30. Risk and protective factors for sporadic Alzheimer's disease. Stozická Z; Zilka N; Novák M Acta Virol; 2007; 51(4):205-22. PubMed ID: 18197729 [TBL] [Abstract][Full Text] [Related]
31. From genetics to dietetics: the contribution of epidemiology to understanding Alzheimer's disease. Barberger-Gateau P; Lambert JC; Féart C; Pérès K; Ritchie K; Dartigues JF; Alpérovitch A J Alzheimers Dis; 2013; 33 Suppl 1():S457-63. PubMed ID: 22683527 [TBL] [Abstract][Full Text] [Related]
32. Alzheimer's dementia: current data review. Uzun S; Kozumplik O; Folnegović-Smalc V Coll Antropol; 2011 Dec; 35(4):1333-7. PubMed ID: 22397284 [TBL] [Abstract][Full Text] [Related]
33. Caffeine as a protective factor in dementia and Alzheimer's disease. Eskelinen MH; Kivipelto M J Alzheimers Dis; 2010; 20 Suppl 1():S167-74. PubMed ID: 20182054 [TBL] [Abstract][Full Text] [Related]
34. A modest proposal for a longitudinal study of dementia prevention (with apologies to Jonathan Swift, 1729). Friedland RP; Nandi S J Alzheimers Dis; 2013; 33(2):313-5. PubMed ID: 22986779 [TBL] [Abstract][Full Text] [Related]
35. Cognitive impairment: dementia and Alzheimer's disease. Larson EB; Kukull WA; Katzman RL Annu Rev Public Health; 1992; 13():431-49. PubMed ID: 1599598 [TBL] [Abstract][Full Text] [Related]
36. The epidemiology of the dementias: an update. Qiu C; De Ronchi D; Fratiglioni L Curr Opin Psychiatry; 2007 Jul; 20(4):380-5. PubMed ID: 17551353 [TBL] [Abstract][Full Text] [Related]
37. Vascular and psychosocial factors in Alzheimer's disease: epidemiological evidence toward intervention. Qiu C; Xu W; Fratiglioni L J Alzheimers Dis; 2010; 20(3):689-97. PubMed ID: 20182015 [TBL] [Abstract][Full Text] [Related]
38. World-Wide FINGERS Network: A global approach to risk reduction and prevention of dementia. Kivipelto M; Mangialasche F; Snyder HM; Allegri R; Andrieu S; Arai H; Baker L; Belleville S; Brodaty H; Brucki SM; Calandri I; Caramelli P; Chen C; Chertkow H; Chew E; Choi SH; Chowdhary N; Crivelli L; Torre R; Du Y; Dua T; Espeland M; Feldman HH; Hartmanis M; Hartmann T; Heffernan M; Henry CJ; Hong CH; Håkansson K; Iwatsubo T; Jeong JH; Jimenez-Maggiora G; Koo EH; Launer LJ; Lehtisalo J; Lopera F; Martínez-Lage P; Martins R; Middleton L; Molinuevo JL; Montero-Odasso M; Moon SY; Morales-Pérez K; Nitrini R; Nygaard HB; Park YK; Peltonen M; Qiu C; Quiroz YT; Raman R; Rao N; Ravindranath V; Rosenberg A; Sakurai T; Salinas RM; Scheltens P; Sevlever G; Soininen H; Sosa AL; Suemoto CK; Tainta-Cuezva M; Velilla L; Wang Y; Whitmer R; Xu X; Bain LJ; Solomon A; Ngandu T; Carrillo MC Alzheimers Dement; 2020 Jul; 16(7):1078-1094. PubMed ID: 32627328 [TBL] [Abstract][Full Text] [Related]
39. Apolipoprotein E epsilon4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging. Hsiung GY; Sadovnick AD; Feldman H CMAJ; 2004 Oct; 171(8):863-7. PubMed ID: 15477624 [TBL] [Abstract][Full Text] [Related]